July 19th, 2019
•The current protocol describes methods to establish patient-derived xenograft (PDX) models and primary cancer cell lines from surgical gastric cancer samples. The methods provide a useful tool for drug development and cancer biology research.
Related Videos
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies Video (Video) | JoVE
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma Video (Video) | JoVE
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis Video (Video) | JoVE
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment Video (Video) | JoVE
A Melanoma Patient-Derived Xenograft Model Video (Video) | JoVE
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models Video (Video) | JoVE
Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells Video (Video) | JoVE
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish Video (Video) | JoVE
The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis Video (Video) | JoVE
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved